Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis

BACKGROUND: In May, 2016, WHO endorsed a 9 month regimen for multidrug-resistant tuberculosis that is cheaper and potentially more effective than the conventional, longer (20–24 month) therapy. We aimed to investigate the population-level implications of scaling up this new regimen. METHODS: In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Kendall, Emily A, Fojo, Anthony T, Dowdy, David W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332590/
https://www.ncbi.nlm.nih.gov/pubmed/27989591
http://dx.doi.org/10.1016/S2213-2600(16)30423-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332590/
https://www.ncbi.nlm.nih.gov/pubmed/27989591
http://dx.doi.org/10.1016/S2213-2600(16)30423-4

Ejemplares similares